Denmark· DK-28106508920
Nexviadyme
A avalglucosidase alfa product containing avalglucosidase alfa, registered in Denmark by Sanofi B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Avalglucosidase alfa is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AB22 (avalglucosidase alfa), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Avalglucosidase alfa · ATC A16AB22
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of avalglucosidase alfa costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Avalglucosidase alfa · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1265.54
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Avalglucosidase alfa
- Manufacturer
- Sanofi B.V.
- Country
- Denmark (DK)
- ATC code
- A16AB22
- ATC class
- Avalglucosidase alfa
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106508920
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A16AB22
Avalglucosidase alfa, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a18217da-c978-42c7-b821-c3a8ba2c8d16 GET /v1/drugs/a18217da-c978-42c7-b821-c3a8ba2c8d16?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "100 mg",
"auth_role": "MOD",
"dk_drugid": "28106508920",
"substance": "Avalglucosidase alfa",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "44736"
}See everything about avalglucosidase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.